Contineum Therapeutics (CTNM) Non Operating Income (2023 - 2026)
Contineum Therapeutics (CTNM) reported Non Operating Income of $2.27 million for Q3 2026, up 6.0% from $2.14 million a year earlier but down 0.2% from the prior quarter.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Non Operating Income (2023 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Contineum Therapeutics' Non Operating Income came in at $8.95 million, up 4.0% year-over-year; for FY2025, it came in at $8.08 million, down 6.4% from FY2024.
- By year, Non Operating Income came in at $8.64 million in FY2024 (+21.8%) and $7.09 million in FY2023.
- Five-year quarterly Non Operating Income spans a low of $291,000 in Q1 2023 and a high of $3.36 million in Q2 2023.
- Year over year, Non Operating Income has now increased in each of the last three quarters, with growth averaging 10.0% over the last eight quarters.
- The high point for year-over-year Non Operating Income in five years was Q1 2024 (growth of 419.9%); the low point was Q2 2024 (a decline of 42.3%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $2.27 million (Q2 2026), $2.45 million (Q1 2026) and $1.96 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Contineum Therapeutics | 405.40 Mn | -584.86 Mn | - | 2.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.27 Mn |
| Jun 30, 2026 | 2.27 Mn |
| Mar 31, 2026 | 2.45 Mn |
| Dec 31, 2025 | 1.96 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 2.48 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 1.75 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Jun 30, 2023 | 3.36 Mn |
| Mar 31, 2023 | 291,000.00 |
API Access
Contineum Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=CTNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "CTNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=CTNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();